These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 19781047

  • 1. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX.
    BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
    [Abstract] [Full Text] [Related]

  • 2. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M, Isaoglu U, Delibas IB, Kadanali S.
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [Abstract] [Full Text] [Related]

  • 3. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS.
    Diamanti-Kandarakis E, Panidis D.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):735-42. PubMed ID: 17760884
    [Abstract] [Full Text] [Related]

  • 4. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199
    [Abstract] [Full Text] [Related]

  • 5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 16; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 6. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A.
    J Clin Endocrinol Metab; 2010 Sep 16; 95(9):4399-405. PubMed ID: 20610596
    [Abstract] [Full Text] [Related]

  • 7. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR.
    Hum Reprod; 2013 May 16; 28(5):1361-8. PubMed ID: 23503943
    [Abstract] [Full Text] [Related]

  • 8. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.
    Arch Gynecol Obstet; 2013 Mar 16; 287(3):525-31. PubMed ID: 23108387
    [Abstract] [Full Text] [Related]

  • 9. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Arch Gynecol Obstet; 2016 Feb 16; 293(2):447-56. PubMed ID: 26408006
    [Abstract] [Full Text] [Related]

  • 10. Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.
    Mes-Krowinkel MG, Louwers YV, Mulders AG, de Jong FH, Fauser BC, Laven JS.
    Fertil Steril; 2014 Jun 16; 101(6):1757-65.e1. PubMed ID: 24680368
    [Abstract] [Full Text] [Related]

  • 11. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.
    Tripathy P, Sahu A, Sahu M, Nagy A.
    Eur J Obstet Gynecol Reprod Biol; 2018 May 16; 224():60-65. PubMed ID: 29550643
    [Abstract] [Full Text] [Related]

  • 12. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F.
    Front Endocrinol (Lausanne); 2022 May 16; 13():825528. PubMed ID: 35299965
    [Abstract] [Full Text] [Related]

  • 13. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD.
    Am J Obstet Gynecol; 2008 Jun 16; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [Abstract] [Full Text] [Related]

  • 14. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr 16; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 15. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM, Wass JA, McCarthy MI, Franks S.
    Clin Endocrinol (Oxf); 2007 Apr 16; 66(4):513-7. PubMed ID: 17371468
    [Abstract] [Full Text] [Related]

  • 16. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.
    Moro F, Tropea A, Scarinci E, Federico A, De Simone C, Caldarola G, Leoncini E, Boccia S, Lanzone A, Apa R.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug 16; 191():101-5. PubMed ID: 26115053
    [Abstract] [Full Text] [Related]

  • 17. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E, Dilbaz B, Cirik DA, Ozelci R, Ozkaya E, Dilbaz S.
    J Obstet Gynaecol Res; 2016 Jul 16; 42(7):837-43. PubMed ID: 27071345
    [Abstract] [Full Text] [Related]

  • 18. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J, Hofer D, Trummer C, Ulbing M, Harger A, Pieber T, Owen L, Keevil B, Brabant G, Lerchbaum E, Obermayer-Pietsch B.
    J Clin Endocrinol Metab; 2015 Feb 16; 100(2):653-60. PubMed ID: 25387259
    [Abstract] [Full Text] [Related]

  • 19. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N, Pehlivanov B, Orbecova M, Uchikova E, Ivancheva H.
    Akush Ginekol (Sofiia); 2014 Feb 16; 53(5):22-7. PubMed ID: 25558667
    [Abstract] [Full Text] [Related]

  • 20. A 20-year follow-up of young women with polycystic ovary syndrome.
    Carmina E, Campagna AM, Lobo RA.
    Obstet Gynecol; 2012 Feb 16; 119(2 Pt 1):263-9. PubMed ID: 22270277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.